*Hansen JB et al. (2011) The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis. J Lipids. 2011:271062 doi:10.1155/2011/271062*Papakostas GI (2011) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Molecular Psychiatry doi:10.1038/mp.2011.166*Wang Y et al. (2011) Development of a Sensitive ELISA to Quantify Apolipoprotein CIII in Non-human Primate Serum. J Lipid Res. 52(6):1265-1271*Hyysalo J (2012) Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2012 May;27(5):951-956 *Pi B et al. (2012) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application number: US20120178118 A1*Sakamoto H et al. (2012) An Apolipoprotein CIII-Derived Peptide, Hatktak, Activates Macromolecular Activators of Phagocytosis from Platelets (MAPPs). Lipoproteins - Role in Health and Diseases. Chapter 31. p.721-740*Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1*Lee JH et al. (2013) Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol. 2013 Oct;70(4):265-84. doi: 10.1111/aji.12142. Epub 2013 Jul 30 *Nichols SKF et al. (2013) Impaired lipid transport in gestational diabetes mellitus. Journal of Diabetes Research & Clinical Metabolism. doi: 10.724/2050-0866-2-22 *Pi B and Bilello J (2013) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application EP20110846638*Riwanto M et al. (2013) Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation. 127(8):891-904 * Richard C et al. (2014) Effect of Mediterranean Diet With and Without Weight Loss on Apolipoprotein B100 Metabolism in Men With Metabolic Syndrome. Arterioscler Thromb Vasc Biol. 34:433-438*Bridge SH et al.(2015) PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism. J Hepatol. 2015 Apr;62(4):763-70. Epub 2014 Nov 21* Sandin A et al. (2015) QUANTITATIVE DETERMINATION OF PROTEIN APOCIII IN SERUM: COMPARISON OFTHREE ASSAY METHODS. Clin. Chem Lab Med 2015:53, Special Suppl, pp S248* Hyysalo J (2017) PREVALENCE AND GENETICS OF NON-ALCOHOLIC FATTY LIVER DISEASE. University of Helsinki. * Colombo M et al. (2018) Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes. Atherosclerosis.274:182-190